MX2009004070A - Terapia de combinacion consecutiva. - Google Patents
Terapia de combinacion consecutiva.Info
- Publication number
- MX2009004070A MX2009004070A MX2009004070A MX2009004070A MX2009004070A MX 2009004070 A MX2009004070 A MX 2009004070A MX 2009004070 A MX2009004070 A MX 2009004070A MX 2009004070 A MX2009004070 A MX 2009004070A MX 2009004070 A MX2009004070 A MX 2009004070A
- Authority
- MX
- Mexico
- Prior art keywords
- combination therapy
- sequential combination
- angiogenesis
- related disorders
- administration
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title 1
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 101100481404 Danio rerio tie1 gene Proteins 0.000 abstract 1
- 101100481406 Mus musculus Tie1 gene Proteins 0.000 abstract 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 abstract 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se describen nuevos métodos para el tratamiento de enfermedades relacionadas con la angiogénesis. Las enfermedades relacionadas con la angiogénesis son tratadas mediante la administración de un agente de enlace de ectodominio Tie1 y un agente antagonista de VEGF.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85226306P | 2006-10-17 | 2006-10-17 | |
US87573606P | 2006-12-19 | 2006-12-19 | |
PCT/US2007/081621 WO2008048996A2 (en) | 2006-10-17 | 2007-10-17 | Sequential combination therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009004070A true MX2009004070A (es) | 2009-04-27 |
Family
ID=39314809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009004070A MX2009004070A (es) | 2006-10-17 | 2007-10-17 | Terapia de combinacion consecutiva. |
Country Status (17)
Country | Link |
---|---|
US (1) | US20080160019A1 (es) |
EP (1) | EP2073826A4 (es) |
JP (1) | JP2010506951A (es) |
KR (1) | KR20090067214A (es) |
AU (1) | AU2007311092A1 (es) |
BR (1) | BRPI0717760A2 (es) |
CA (1) | CA2666714A1 (es) |
CR (1) | CR10798A (es) |
EA (1) | EA200900562A1 (es) |
EC (1) | ECSP099336A (es) |
IL (1) | IL198026A0 (es) |
MA (1) | MA30901B1 (es) |
MX (1) | MX2009004070A (es) |
NI (1) | NI200900057A (es) |
NO (1) | NO20091375L (es) |
TN (1) | TN2009000136A1 (es) |
WO (1) | WO2008048996A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007528720A (ja) * | 2003-08-12 | 2007-10-18 | ダイアックス コーポレイション | Tie1結合リガンド |
WO2005107461A2 (en) * | 2004-04-07 | 2005-11-17 | The General Hospital Corporation | Modulating lymphatic function |
US20080213253A1 (en) * | 2007-01-12 | 2008-09-04 | Dyax Corp. | Combination therapy for the treatment of cancer |
EP2156834A1 (en) * | 2008-08-08 | 2010-02-24 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic pharmaceutical compositions comprising Sorafenib for the treatment of neoangiogenic pathologies of the eye |
EP2552482A2 (en) * | 2010-03-31 | 2013-02-06 | Université de Genève | Stabilized antibody preparations and uses thereof |
US9804675B2 (en) | 2013-06-27 | 2017-10-31 | Elwha Llc | Tactile feedback generated by non-linear interaction of surface acoustic waves |
US20150003204A1 (en) * | 2013-06-27 | 2015-01-01 | Elwha Llc | Tactile feedback in a two or three dimensional airspace |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0010017A (pt) * | 1999-04-28 | 2002-06-11 | Univ Texas | Composições e processos para o tratamento de câncer por inibição seletiva de vegf |
US20040132675A1 (en) * | 2002-02-08 | 2004-07-08 | Calvin Kuo | Method for treating cancer and increasing hematocrit levels |
JP2007528720A (ja) * | 2003-08-12 | 2007-10-18 | ダイアックス コーポレイション | Tie1結合リガンド |
US7485297B2 (en) * | 2003-08-12 | 2009-02-03 | Dyax Corp. | Method of inhibition of vascular development using an antibody |
US7871610B2 (en) * | 2003-08-12 | 2011-01-18 | Dyax Corp. | Antibodies to Tie1 ectodomain |
AU2005272848A1 (en) * | 2004-08-12 | 2006-02-23 | Dyax Corp. | Tie complex binding proteins |
US20080213253A1 (en) * | 2007-01-12 | 2008-09-04 | Dyax Corp. | Combination therapy for the treatment of cancer |
-
2007
- 2007-10-17 BR BRPI0717760-7A2A patent/BRPI0717760A2/pt not_active IP Right Cessation
- 2007-10-17 EP EP07854125A patent/EP2073826A4/en not_active Withdrawn
- 2007-10-17 MX MX2009004070A patent/MX2009004070A/es unknown
- 2007-10-17 AU AU2007311092A patent/AU2007311092A1/en not_active Abandoned
- 2007-10-17 US US11/873,856 patent/US20080160019A1/en not_active Abandoned
- 2007-10-17 CA CA002666714A patent/CA2666714A1/en not_active Abandoned
- 2007-10-17 JP JP2009533500A patent/JP2010506951A/ja not_active Withdrawn
- 2007-10-17 WO PCT/US2007/081621 patent/WO2008048996A2/en active Application Filing
- 2007-10-17 EA EA200900562A patent/EA200900562A1/ru unknown
- 2007-10-17 KR KR1020097009954A patent/KR20090067214A/ko not_active Application Discontinuation
-
2009
- 2009-03-31 NO NO20091375A patent/NO20091375L/no not_active Application Discontinuation
- 2009-04-06 IL IL198026A patent/IL198026A0/en unknown
- 2009-04-13 TN TNP2009000136A patent/TN2009000136A1/fr unknown
- 2009-04-16 NI NI200900057A patent/NI200900057A/es unknown
- 2009-05-14 MA MA31888A patent/MA30901B1/fr unknown
- 2009-05-15 EC EC2009009336A patent/ECSP099336A/es unknown
- 2009-05-15 CR CR10798A patent/CR10798A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2008048996A2 (en) | 2008-04-24 |
NO20091375L (no) | 2009-07-10 |
EA200900562A1 (ru) | 2009-10-30 |
CR10798A (es) | 2009-06-09 |
JP2010506951A (ja) | 2010-03-04 |
AU2007311092A1 (en) | 2008-04-24 |
EP2073826A2 (en) | 2009-07-01 |
WO2008048996A3 (en) | 2008-07-03 |
NI200900057A (es) | 2010-02-02 |
TN2009000136A1 (en) | 2010-10-18 |
ECSP099336A (es) | 2009-06-30 |
KR20090067214A (ko) | 2009-06-24 |
MA30901B1 (fr) | 2009-11-02 |
BRPI0717760A2 (pt) | 2013-11-12 |
CA2666714A1 (en) | 2008-04-24 |
US20080160019A1 (en) | 2008-07-03 |
WO2008048996A9 (en) | 2008-09-12 |
IL198026A0 (en) | 2011-08-01 |
EP2073826A4 (en) | 2010-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL179515A0 (en) | Method of administering and using vegf inhibitors for the treatment of human cancer | |
TN2009000136A1 (en) | Sequential combination therapy | |
HK1139930A1 (en) | Cyclopamine lactam analogs and methods of use thereof | |
MX2007008756A (es) | Uso de metilnaltrexona y compuestos relacionados para el tratamiento de disfuncion gastrointestinal postoperatoria. | |
MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
EP2165715A4 (en) | THERAPEUTIC AGENT FOR CANCER AND METHOD FOR TREATING CANCER | |
MY198422A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
HK1120441A1 (en) | Drugs for treatment of ovarian cancer | |
WO2008095086A3 (en) | Topiramate plus naltrexone for the treatment of addictive disorders | |
MX2009008132A (es) | Terapia de combinacion con inhibidores de angiogenesis. | |
WO2008073509A3 (en) | Compositions and methods for treating a neoplasm | |
WO2010014595A3 (en) | Methods and compositions for delivering therapeutic agents in the treatment of b-cell related disorders | |
TN2010000214A1 (en) | Methods for treating obesity and obesity related diseases and disorders | |
IL198723A0 (en) | Methods and compositions for therapeutic treatment | |
EP2263705A4 (en) | THERAPEUTIC AGENT AGAINST NERVE INJURY AND METHOD FOR TREATING NERVE INJURY | |
MY160406A (en) | Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent | |
IL200525A0 (en) | Methods of treating cancer by administering human il-18 combinations | |
WO2008089070A3 (en) | Combination therapy for the treatment of cancer | |
EP2029156A4 (en) | POLY THERAPY FOR TREATING CANCER | |
TN2009000490A1 (en) | Cancer treatment combination therapy comprising vinflunine and trastuzumab | |
IL193799A0 (en) | New therapeutic combinations for the treatment or prevention of psycotic disorders | |
HK1102626A1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
ZA200810199B (en) | Rinse-off therapeutic agents for treating skin | |
IL206435A0 (en) | Therapeutic regimens for the treatment of immunoinflammatory disorders | |
EA200901062A1 (ru) | Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств |